Working… Menu

Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00625651
Recruitment Status : Completed
First Posted : February 28, 2008
Last Update Posted : April 25, 2014
Information provided by (Responsible Party):